Results 141 to 150 of about 42,696 (223)

Limitations of human t-lymphotropic virus type 1 antibody testing in hospitals of endemic regions in China. [PDF]

Front Cell Infect Microbiol
Chen Y, Chen Y, Zheng J, Yang J, Wu Y, Hu J, Wu Z.   +6 more
europepmc   +1 more source

An unusual case: Adult T-cell leukemia/lymphoma in pediatric patient with human T-lymphotropic virus 1 infection. Clinical implications and therapeutic challenges. [PDF]

JAAD Case Rep
Benavides-Tulcan EY, Gutierrez-Gomez M, Rueda-Plata RA.   +2 more
europepmc   +1 more source

Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study. [PDF]

Front Microbiol, 2021
Melo Bandeira L, Moreira Puga MA, Croda J, Pompílio MA, Amianti C, Rocha de Rezende G, Coimbra Motta-Castro AR.   +6 more
europepmc   +1 more source

Darifenacin Versus Parasacral Transcutaneous Electric Nerve stimulation for overactive bladder syndrome in patients infected with Human T-Lymphotropic Virus 1 - randomized open clinical trial. [PDF]

Int Braz J Urol
de Oliveira TSS, C JA, Oliveira CJV, Castro NM, Carvalho EM.   +4 more
europepmc   +1 more source

Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection. [PDF]

Clin Microbiol Rev, 2022
Legrand N, McGregor S, Bull R, Bajis S, Valencia BM, Ronnachit A, Einsiedel L, Gessain A, Kaldor J, Martinello M.   +9 more
europepmc   +1 more source

Histopathological differences between human T-lymphotropic virus type 1-positive and human T-lymphotropic virus type 1-negative polymyositis [PDF]

Clinical and Experimental Neuroimmunology, 2011
Hazem M. Abdullah, Itsuro Higuchi, Ryuji Kubota, Eiji Matsuura, Akihiro Hashiguchi, Nashwa H. Abdelbary, Yukie Inamori, Hiroshi Takashima, Shuji Izumo   +8 more
openaire   +1 more source

First report on human T-lymphotropic virus 1 infection in a group of transgender women. [PDF]

Front Public Health
Carneiro MADS, Margarida MCA, Silva BVDE, Silva ÁMDCE, de Matos MAD, Caetano KAA, Teles SA, Vallinoto ACR, Martins RMB.   +8 more
europepmc   +1 more source

Immigrating and vicinity are not risk factors in the prevalence and transmission rate of human T-lymphotropic virus type 1: A Survey in an endemic region of Iran and Afghan refugees. [PDF]

PLOS Glob Public Health, 2023
Mahdifar M, Akbari-Eidgahi MR, Mosavat A, Pourreza A, Akbarin MM, Valizadeh N, Rezaee SA, Rafatpanah H.   +7 more
europepmc   +1 more source

Lessons from human T‐lymphotropic virus testing [PDF]

Transfusion, 2011
openaire   +1 more source

Human T-Lymphotropic Virus-1 Associated With Adult T-Cell Lymphoma: A Case Report. [PDF]

Cureus
Le Gatt P, Pinana M, Reimbold P, Boussen I, Lescaille G, Rochefort J.   +5 more
europepmc   +1 more source